Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$49.31 /

+0.95 (+1.96%)

, MRK

Merck

$89.29 /

+0.11 (+0.12%)

07:48
12/17/19
12/17
07:48
12/17/19
07:48

FDA Oncologic Drugs Advisory Committee to hold a meeting

The Committee discusses AstraZeneca's supplemental New Drug Application (sNDA) 208558/010 for LYNPARZA (Olaparib) Tablets for the proposed indication of maintenance treatment of adults with deleteriour or suspected deleterious gBRCAm metastatic adenocarcinoma of the pancreas. Also to be discussed is Merck Sharpe & Dohme Corp's supplemental Biologics License Application (sBLA) 125514/066 for KEYTRUDA (Pembrolizumab) for injection. The proposed indication for KEYTRUDA is for treatment of patients with bacillus Calmette-Guerin-unresponsive, high-risk, non-muscle invasive bladder cancer with carcinoma in-situ with or without papillary tumors. The meeting will be held at the FDA Silver Spring, MD offices on December 17 at 8 am. Webcast Link

AZN

AstraZeneca

$49.31 /

+0.95 (+1.96%)

MRK

Merck

$89.29 /

+0.11 (+0.12%)

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

AZN AstraZeneca
$49.31 /

+0.95 (+1.96%)

12/16/19 Stifel
Stifel 'taking profits' on Amarin following FDA approval, downgrades to Hold
12/12/19 H.C. Wainwright
Zymeworks may have work-around to AEs of competing drug, says H.C. Wainwright
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
12/02/19 Cowen
AstraZeneca price target raised to $55 from $48 at Cowen
MRK Merck
$89.29 /

+0.11 (+0.12%)

12/12/19 Stifel
Stifel says TherapeuticsMD's Annovera 'insulated' against generic NuvaRing
12/10/19 Roth Capital
ArQule downgraded to Neutral from Buy at Roth Capital
12/10/19 Cantor Fitzgerald
ArQule downgraded to Neutral from Overweight at Cantor Fitzgerald
12/10/19 H.C. Wainwright
ArQule downgraded to Neutral from Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Initiation
SI-Bone initiated with a Buy at Needham » 05:28
02/19/20
02/19
05:28
02/19/20
05:28
SIBN

SI-Bone

$20.60 /

+0.07 (+0.34%)

Needham analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Chiyoda downgraded to Hold from Buy at Jefferies » 05:25
02/19/20
02/19
05:25
02/19/20
05:25
CHYCY

Chiyoda

$0.00 /

+ (+0.00%)

Jefferies analyst Thanh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Varta upgraded to Hold from Reduce at Commerzbank » 05:23
02/19/20
02/19
05:23
02/19/20
05:23
VARGF

Varta

$0.00 /

+ (+0.00%)

Commerzbank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Golden Ocean upgraded to Hold from Sell at Pareto » 05:22
02/19/20
02/19
05:22
02/19/20
05:22
GOGL

Golden Ocean

$4.51 /

-0.08 (-1.74%)

Pareto analyst Eirik…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Cognizant initiated with an Underweight at Atlantic Equities » 05:19
02/19/20
02/19
05:19
02/19/20
05:19
CTSH

Cognizant

$68.83 /

+0.38 (+0.56%)

Atlantic Equities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Accenture initiated with an Overweight at Atlantic Equities » 05:19
02/19/20
02/19
05:19
02/19/20
05:19
ACN

Accenture

$213.78 /

+1.4 (+0.66%)

Atlantic Equities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Fortescue Metals downgraded to Underperform from Sector Perform at RBC Capital » 05:19
02/19/20
02/19
05:19
02/19/20
05:19
FSUGY

Fortescue Metals

$0.00 /

+ (+0.00%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Fluor downgraded to Hold from Buy at Canaccord » 05:17
02/19/20
02/19
05:17
02/19/20
05:17
FLR

Fluor

$14.80 /

-4.74 (-24.26%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Epiroc downgraded to Reduce from Hold at Kepler Cheuvreux » 05:16
02/19/20
02/19
05:16
02/19/20
05:16
EPOKY

Epiroc

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Agilent price target raised to $96 from $86 at Piper Sandler » 05:15
02/19/20
02/19
05:15
02/19/20
05:15
A

Agilent

$84.75 /

-1.1 (-1.28%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Eaton forms joint venture with Abunayyan Holding » 05:14
02/19/20
02/19
05:14
02/19/20
05:14
ETN

Eaton

$104.44 /

+0.88 (+0.85%)

Eaton and Abunayyan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
AtriCure price target raised to $50 from $40 at Piper Sandler » 05:12
02/19/20
02/19
05:12
02/19/20
05:12
ATRC

AtriCure

$43.15 /

-0.73 (-1.66%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genentech says Tecentriq granted priority review by FDA » 05:12
02/19/20
02/19
05:12
02/19/20
05:12
RHHBY

Roche

$0.00 /

+ (+0.00%)

Genentech, a member of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Outfront Media price target raised to $35 from $32 at Imperial Capital » 05:10
02/19/20
02/19
05:10
02/19/20
05:10
OUT

Outfront Media

$30.87 /

+0.02 (+0.06%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Bluebird pushed Biologics License Application to second half, says Piper Sandler » 05:09
02/19/20
02/19
05:09
02/19/20
05:09
BLUE

Bluebird Bio

$88.16 /

-0.98 (-1.10%)

The Zynteglo European…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dentsply Sirona added to Select List, target raised to $66 at Stifel » 05:04
02/19/20
02/19
05:04
02/19/20
05:04
XRAY

Dentsply Sirona

$57.91 /

+0.12 (+0.21%)

Stifel analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Culp, Inc. downgraded to Hold from Buy at Stifel » 05:00
02/19/20
02/19
05:00
02/19/20
05:00
CULP

Culp, Inc.

$11.07 /

-0.68 (-5.79%)

Stifel analyst John Baugh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Diamondback Energy doubles dividend to $1.50 per year » 04:57
02/19/20
02/19
04:57
02/19/20
04:57
FANG

Diamondback Energy

$74.55 /

-0.39 (-0.52%)

Diamondback Energy said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Independent Bank management to meet with Piper Sandler » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
IBCP

Independent Bank

$21.63 /

-0.38 (-1.73%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
TriNet management to meet with JPMorgan » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
TNET

TriNet

$58.55 /

-2.46 (-4.03%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Arista Networks management to meet with Oppenheimer » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
ANET

Arista Networks

$225.79 /

+2.48 (+1.11%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Fortinet management to meet with Oppenheimer » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
FTNT

Fortinet

$119.45 /

+0.25 (+0.21%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Azure Power management to meet with Roth Capital » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
AZRE

Azure Power

$13.80 /

+0.1 (+0.73%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Envision Solar management to meet with Maxim » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
EVSI

Envision Solar

$10.25 /

+0.545 (+5.62%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
ON Semiconductor management to meet with Needham » 04:55
02/19/20
02/19
04:55
02/19/20
04:55
ON

ON Semiconductor

$21.11 /

-0.34 (-1.59%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.